All Updates

All Updates

icon
Filter
Earnings/results
Zoom trades lower as upgraded Q3 guidance fails to impress
Remote Work Tools
Aug 29, 2021
This week:
Partnerships
Twelve Labs partners with AWS to make videos searchable
Foundation Models
Yesterday
Partnerships
Apple discloses use of AWS GenAI chips at re:Invent 2024 conference
Generative AI Infrastructure
Yesterday
Product updates
AWS launches Automated Reasoning checks to combat AI hallucinations
Generative AI Infrastructure
Yesterday
Partnerships
Allianz Partners and Uber partner to launch vehicle interruption cover for UK drivers
InsurTech: Commercial Lines
Dec 3, 2024
Funding
Jove Insurance raises USD 4.4 million in seed funding for product enhancement
InsurTech: Commercial Lines
Dec 3, 2024
Funding
Orakl Oncology raises EUR 11 million in seed funding to commercialize products
AI Drug Discovery
Dec 3, 2024
FDA approval
Lantern Pharma receives second FDA Fast Track Designation for LP-184 oncology candidate
AI Drug Discovery
Dec 3, 2024
Partnerships
AI Proteins partners with BMS to develop novel mini-protein-based therapeutics
AI Drug Discovery
Dec 3, 2024
Partnerships
Product updates
SoftServe introduces GenAI drug discovery solution with NVIDIA
AI Drug Discovery
Dec 3, 2024
Funding
Maze Therapeutics raises USD 115 million in Series D funding to develop pipeline programs
Precision Medicine
Dec 3, 2024
Remote Work Tools

Remote Work Tools

Aug 29, 2021

Zoom trades lower as upgraded Q3 guidance fails to impress

Earnings/results

  • Zoom reported a non-GAAP EPS of USD 1.36 for Q2 FY2022, exceeding analyst consensus expectations of USD 1.16 (an earnings surprise of 17%), and grew 48% year-over-year (YoY). Zoom’s revenue rose 54% YoY to USD 1.02 billion, beating consensus expectations by 3%. However, quarter-on-quarter (QoQ) revenue growth decelerated to 6.8% as schools reopened and workplaces relaxed remote work policies as the vaccination drive picked up.

  • Zoom’s stock traded 11% lower in after-hours trading due to the company’s upgraded guidance for Q3 coming in below analyst estimates. Zoom guided for revenue between USD 1.015-1.02 billion (vs analyst estimates of USD 1.02 billion) and non-GAAP EPS of 1.07 (vs analyst estimates of 1.10) for Q3 FY2022.

  • The Q2 revenue growth was supported by a 131% YoY increase (about 14% QoQ) of active customers (trailing 12-month revenue greater than USD 100,000) to around 2,280. Customers with more than 10 employees on the platform rose 36% YoY to 504,900 and the net dollar expansion rate among these customers was reported to be above 130% for the 13th consecutive quarter. The Americas region accounted for 67% of total revenue and posted YoY growth of 50%.

  • Zoom’s non-GAAP gross margin improved by about 390 basis points to 76.2% in Q2 FY2022 compared to the previous year. The improvement was attributed to the activation of new data center capacity. Non-GAAP income from operating rose 53% YoY to USD 425 million with a steady margin of 42% compared to the previous year.

  • The company’s full-year revenue guidance for FY2022 was marginally upgraded to roughly USD 4 billion (from roughly USD 3.98 billion) implying revenue growth of around 52% YoY. Non-GAAP income from operations was projected to be USD 1.5 billion, implying growth of around 54% YoY. Zoom upgraded EPS guidance to between USD 4.75-4.79, implying a growth of 43-44% YoY.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.